While BRCA1/2 mutations are prototypical causes of HRD, our findings suggest that CDCP1 expression could represent a non-BRCA indicator of genomic instability in PDAC [24-26]. Here, CDCP1 is linked to hypoparathyroidism-retardation-dysmorphism syndrome.